Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency
about
Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency
description
clinical trial
@en
klinisch onderzoek
@nl
name
Safety and Tolerability of Vil ...... or Severe Renal Insufficiency
@en
type
label
Safety and Tolerability of Vil ...... or Severe Renal Insufficiency
@en
prefLabel
Safety and Tolerability of Vil ...... or Severe Renal Insufficiency
@en
P17
P1050
P1476
A Multi-center, Randomized, Do ...... or Severe Renal Insufficiency
@en
P3098
NCT00646542
P4844
P580
2005-03-01T00:00:00Z
P582
2010-10-01T00:00:00Z